Review on 'para-Alkoxyphenols': an important group of antimelanoma compounds

Rina Mondal

doi:10.32628/IJSRST52411250

Authors

Rina Mondal Assistant Professor, Department of Chemistry, Uluberia College, Howrah, West Bengal, India Author

DOI:

https://doi.org/10.32628/IJSRST52411250

Keywords:

Para-Alkoxyphenol, Antimelanoma Compounds, RNR, Cytotoxicity And Radical Scavenger

Abstract

Melanoma is the most lethal cancer of the skin, and the number of incidence of melanoma worldwide has doubled in the past twenty years. Once malignant melanoma has progressed to the metastatic stage, it becomes refractory to treatment with currently available therapies.p-alkoxyphenols form an important group of antimelanoma compounds.

Downloads

Download data is not yet available.

References

Lassmann, G.; Pötsch, S. Free Radical Biology and Medicine, 1995, 19, 533-539. (b) Riley, P. A. Hydroxyanisole: The current status; In: Hydroxyanisole Recent Advance in Anti-melanoma Therapy; Riley, P. A., ed. Oxford: IRL Press; 1984. (c) Morgan, B. D. G.; Recent Results of a Clinical Pilot Study of Intra Arterial 4HA Chemotherapy in Malignant Melanoma. In: Hydroxyanisole Recent Advance in Anti-melanoma Therapy. Riley, P. A., ed. Oxford: IRL Press; 1984. (d) Naish-Byfield, S.; Cooksey, C. J.; Latter, A. M.; Johnson, C. I.; Riley, P. A. Melanoma Res. 1991, 1, 273-287. (e) Meyers, R. O.; Lambert, J. D.; Hajicek, N.; Pourpak, A.; Kalaitzis J.A.; Dorr, R. T. Bioorg. Med. Chem. Lett. 2009, 19, 4752–4755. (f) Chatterjee, P.; Kouzi, S. A. ; Pezzuto, J. M.; Hamann, M. T. Appl. Environ. Microbiol. 2000, 66, 3850-3855. (g) Lant, N. J.; McKeown, P.; Kelland, L. R.; Rogers, P. M.; Robins, D. J. Anticancer Drug Des. 2000, 15, 295-302.

(a) Luo, J.; Gräslund, A. Arch. Biochem. Biophys. 2011, 516, 29-34. (b) Potsch, S.; Drechsler, H.; Liermann, B.; Graslund, A.; Lassmann. G. Mol. Pharmcol. 1994, 45, 792-796.

(a) Moridani, M. Y.; Moore, M.; Bartsch, R. A.; Yang, Y.; Heibati-Sadati, J. Pharm. Pharmaceut. Sci. 2005, 8, 348-360. (b) Moridani, M. Y. Cancer Lett. 2006, 243, 235–245. (c) Riley, P. A.; Cooksey, C. J.; Johnson, C.I.; Land, E. J.; Latter, A. M.; Ramsden, C. A. Eur. J. Cancer, 1997, 33, 135-143.

(a) Lassmann, G.; Pötsch, S. Biol. Med. 1995, 19, 533-539. (b) Pötsch, S.; Drechsler, H.; Liermann, B.; Gräslund, A.; Lassmann, G. FEBS Lett. 1995, 374, 95-99. (c) Wellnitz, U.; Pötsch, S.; Garbe, C.; Lassmann, G. Melanoma Res. 1997, 7, 288-298.

Kadoma,Y.; Murakami, Y.; Ogiwara, T.; Machino, M.; Yokoe, I.; Fujisawa, S. Molecules, 2010, 15, 1103-1112.

(a) Robinson, R.; Smith, J. C. J. Chem. Soc. 1926, 392-401. (b) Zhang, Z. Y.; Lu, W. F.; Shi, Y. Z. Chin. J. Appl. Chem. 1994, 11, 14. (c) Newman, M.S. Cella, J. A. J. Org. Chem., 1974, 39, 214-215. (d) Rosenwald, R. H.; Plaines, D. US Patent 2,781,404, 1957. (e) Telschow, J. E. U.S. Patent 4,614,814, 1986.

(a) Grote, H. W.; U.S. Patent 2,615,051, 1952. (b) Nagai, S.; Yoshida, H.; Inoue, T. U.S. Patent 4,025,566, 1977. (c) Neumann, R.; Schwarz, H.-H. U.S. Patent 4,307,253, 1981. (d) Bellas, M.; Cahill, R. U.S. Patent 4,294,991, 1981. (e) Rivetti, F.; Romano, U.; Muzio, N. D. U.S. Patent 4,469,897, 1984. (f) Green, M. J. U.S. Patent 4,700,005,14987, 1987. (g) Correale, M.; Panseri, P.; Romano, U. Minisci, F. U.S. Patent 4,933,504, 1990. (h) Shiomi, Y.; Nakamura, Y.; Manabe, T.; Furusaki, S.; Matsuda, M.; Saito, M. U.S. Patent 5,248,835, 1993. (i) Satoh, T.; Matsumoto, H.; Niiro, Y. U.S. Patent 5,416,242, 1995. (j) Satoh, T.; Matsumoto, H.; Niiro, Y. U.S. Patent 36,139, 1999. (k) Ashtekar, S.; Kumbhar, P.; Mahalingam, R. J.; Thampi, J. U.S. Patent 2005/0222372 A1, 2005. (l) Ashtekar, S.; Kumbhar, P.; Mahalingam, R. J.; Thampi, J. U.S. Patent 7,087,705,B2, 2006, (m) Ashtekar, S.; Kumbhar, P.; Mahalingam, R. J.; Thampi, J. Eur. Patent 1 732 870 B1, 2010.

(a) House, H. O. Modern Synthetic Reactions; The Benjamin/Cummings Publishing Company, Menlo Park, California, 1972, pp. 321-328. (b) Norman, R. O. C. and Coxon, J. M., Principles of Organic Synthesis; ELBS with Chapman & Hall, London,1993, pp. 445-446.

(a) Nikaido, M.; Aslanian, R.; Scavo, F.; Helquist, P. J. Org. Chem. 1984, 49, 4740-4741.(b) Pansegrau, P. D.; Munson, B. P. US Patent 5,840,997, 1998.

(a) Dötz, K. H. Angew. Chem., Int. Ed. Engl. 1975, 14, 644 (b) Hegedus, L. S. Tetrahedron, 1997, 53, 4105-4128. (c) Merlic, C. A.; Xu, D. J. Am. Chem. Soc. 1991, 113, 7418-7420. (d) Wang, H.; Huang, J.; Wulff, W. D.; Rheingold, A. L. J. Am. Chem. Soc. 2003, 125, 8980-8981.

(a) Bhatt, M. V.; Babu, J. R. Tetrahedron Lett. 1984, 25, 3497-3500. (b) Pasquini, C.; Coniglio, A.; Bassetti, M. Tetrahedron Lett. 2012, 53, 6191-6194.

Ramirez, F.; Chem, E. H.; Dershowitz, S. J. Am. Chem. Soc. 1959, 81, 4338-4341.

Yadav, G. D.; Deshmukh, S. A. R. K.; Asthana, N. S. Ind. Eng. Chem. Res. 2005, 44, 7969-7977.

R. Mondal, C. Guha, A. K. Mallik, Tetrahedron Lett. 2014, 55, 86-89.